Company profile
Home - Vivan Therapeutics
Vivan Therapeutics' Personal Discovery Process provides individuals with personalised cancer treatment and cancer treatment research on an unprecedented scale.
Financial period: 1 Sep 2023 to 31 Aug 2024
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
SH01 | Transaction MzQ1NjMxODg2NWFkaXF6a2N4
Published 25 Feb 2025 11:39
AA | Transaction MzQ1NjI5NjAxN2FkaXF6a2N4
Published 25 Feb 2025 09:31
SH01 | Transaction MzQ1NjEyMjEzNGFkaXF6a2N4
Published 24 Feb 2025 09:53
SH01 | Transaction MzQ1NjEyMDkwOWFkaXF6a2N4
Published 24 Feb 2025 09:45
CS01 | Transaction MzQ0NDc0NTE4MWFkaXF6a2N4
Published 25 Nov 2024 10:13
SH01 | Transaction MzQzNjQwNTUxM2FkaXF6a2N4
Published 18 Sep 2024 15:14
SH01 | Transaction MzQzNjQwNTE4MmFkaXF6a2N4
Published 18 Sep 2024 15:11
SH01 | Transaction MzQzNjQwNDg3NmFkaXF6a2N4
Published 18 Sep 2024 15:08
SH01 | Transaction MzQzNjQwNDQyOGFkaXF6a2N4
Published 18 Sep 2024 15:04
SH01 | Transaction MzQzNjQwMzg5NGFkaXF6a2N4
Published 18 Sep 2024 15:00
SH01 | Transaction MzQzNTYxNTk4MGFkaXF6a2N4
Published 13 Sep 2024 11:11
Company registered at Companies House
1 Jan 2023 to 31 Dec 2025
Vivan Therapeutics offers personalised cancer therapeutics to patients based on their tumour genetics. For each patient, we build an army of 500,000 genetically matched fruit fly model of the tumour, which is used for large-scale drug screening to find novel & effective drug combinations. This is the only platform allowing personalised in vivo high-throug...
28 Apr 2021 to 28 Apr 2022
My Personal Therapeutics
1 Oct 2020 to 31 Mar 2022
In theory, to find an efficient treatment for cancer we have only to identify an oncogenic mutation and target it with a well characterized drug. In practice, however, every cancer is driven by multiple mutations occurring in unique combinations, which generate a complex tumour network in each patient. When oncologists have tried to practice single-target...
1 Apr 2020 to 30 Apr 2022
AI can improve outcomes in cancer. Oncologists can easily identify all mutations that may be driving cancer, but struggle to identify the best mixture of drugs targeted against these mutations. Only AI systems can realistically make sense of the thousands of potentially oncogenic mutations and drugs that could target them. However, data to feed such AI sy...
